Activation of the canonical nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) pathway may also be implicated in the promotion of the dormant phenotype in breast cancer cells expressing estrogen receptors (ERs) [25]. The gene discussed is NFKB1; the disease is breast cancer.